Concepedia

Thorben Fründt

TF

Statistics

Publications

11

Citations

614

H-Index

11

Active since

2017

Affiliations

Universität Hamburg(Current)

University Medical Center Hamburg-Eppendorf

Goethe University Frankfurt

University Hospital Frankfurt

University Medical Center of the Johannes Gutenberg University Mainz

Thorben Fründt is an author at Universität Hamburg specializing in oncology, medicine, and hepatocellular carcinoma.

ORCID

Publications per year

2017–2024

11

Publications

11

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 300 citations · Full text

, , +17

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen et al. · JHEP Reports · 2022 · 61 citations · Full text

, , +14

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study

Sabrina Welland, Catherine Leyh, Fabian Finkelmeier et al. · Liver Cancer · 2022 · 45 citations · Full text

, , +13

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients

Thorben Fründt, Linda Krause, Elaine Hussey et al. · Cancers · 2021 · 43 citations · Full text

, , +17

Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort

Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh et al. · Liver Cancer · 2021 · 40 citations · Full text

, , +15

1–5 of 11